Skip to content

GNFT

Genfit SA

NASDAQ · Healthcare · Biotechnology · FR

$8.95
+4.07%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
7.59x
Price / sales
9.62x
Price / cash flow
-125.44x

Enterprise value

Enterprise value
$480.6M
EV / sales
10.38x
EV / EBITDA
-18.49x
EV / EBIT
-15.43x
Market cap
$445.5M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2025